{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:30:34Z","timestamp":1790443834442,"version":"4.1.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2023-00251396"],"award-info":[{"award-number":["RS-2023-00251396"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011705","name":"Korea Institute of Marine Science and Technology promotion","doi-asserted-by":"publisher","award":["RS-2025-02292973"],"award-info":[{"award-number":["RS-2025-02292973"]}],"id":[{"id":"10.13039\/501100011705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alzheimer\u2019s disease (AD) is the most common cause of dementia and accounts for approximately 60\u201380% of total dementia patients. Currently, accurate diagnosis for AD relies on cerebrospinal fluid (CSF) sampling or a positron emission tomography (PET) scan, methods that cannot be done in primary care centers where most people go with cognitive complaints. This Limitation calls for the urgent need to develop blood-related diagnostic tests that could facilitate early detection and enable timely treatment. Recent CSF proteomic research categorized AD into five molecular subtypes with discrete Genetic risk profiles. Subtypes 1\u20133, namely neuronal hyperplasticity, innate immune activation, and RNA dysregulation, were characterized by more classical AD-related changes, like accumulation of amyloid\/tau and synaptic and immune dysfunction, respectively. On the contrary, non-traditional AD mechanisms in subtypes 4\u20135 were choroid plexus (CP) dysfunction and blood\u2013brain barrier (BBB) dysfunction, emphasizing clearance deficits in association with brain barrier dysfunction. The unchanged tau levels later may be explained by an alternate disease mechanism (clearance dysfunction). These subtypes included BBB and CP dysfunction. Biomarker identification based on the mechanism of disease progression would increase the precision of diagnoses, allowing for tailored interventions and aiding in the creation of novel therapies for subtypes that might not react favorably to conventional amyloid\/tau-targeting strategies. Finding biomarkers specific to each subtype would aid in patient classification, resulting in more individualized therapy as opposed to a \u201cone-size-fits-all\u201d strategy. The present review emphasized the importance of identifying blood-based biomarkers (BBMs) related to brain barrier dysfunction from CSF studies and personalized treatment strategies to streamline the diagnostic workup, and may be utilized in standard clinical practice for the early detection of AD.<\/jats:p>","DOI":"10.1186\/s40364-025-00829-4","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:03:23Z","timestamp":1758877403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bridging the barrier: insights into blood biomarkers and therapeutic strategies targeting choroid plexus and BBB dysfunction in alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Niti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himadri","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayoung","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Min","family":"Pyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Sik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Rai","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geon Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YoungSoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Chul","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo A.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangYun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Alzheimer\u2019s Disease All Markers (ADAM) Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"1","key":"829_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):40. https:\/\/doi.org\/10.1186\/s13024-020-00391-7.","journal-title":"Mol Neurodegener"},{"issue":"6248","key":"829_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein. Science. 2015;349(6248):1255555. https:\/\/doi.org\/10.1126\/science.1255555.","journal-title":"Science"},{"key":"829_CR3","doi-asserted-by":"publisher","unstructured":"Association As. Alzheimer\u2019s Disease Facts and Figures. Alzheimers Dement. 2025;21:e70235.https:\/\/doi.org\/10.1002\/alz.70235.","DOI":"10.1002\/alz.70235"},{"key":"829_CR4","unstructured":"Frank A. Alzheimer\u2019s Disease: Accurate diagnosis ensures appropriate prescribing and treatment for Alzheimer\u2019. Today\u2019s Geriatric Medicine. 2023.https:\/\/www.todaysgeriatricmedicine.com\/archive\/ND23p8.shtml.(2 July, 2025)."},{"issue":"4","key":"829_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.12779\/dnd.2024.23.4.188","volume":"23","author":"HS Kwon","year":"2024","unstructured":"Kwon HS, Yu H-J, Koh S-H. Revolutionizing Alzheimer\u2019s diagnosis and management: the dawn of biomarker-based precision medicine. Dement Neurocogn Disord. 2024;23(4):188\u2013201. https:\/\/doi.org\/10.12779\/dnd.2024.23.4.188.","journal-title":"Dement Neurocogn Disord"},{"issue":"8","key":"829_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","volume":"17","author":"AM Brickman","year":"2021","unstructured":"Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, et al. Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study. Alzheimers Dement. 2021;17(8):1353\u201364. https:\/\/doi.org\/10.1002\/alz.12301.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"829_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01513-9","volume":"16","author":"J Arranz","year":"2024","unstructured":"Arranz J, Zhu N, Rubio-Guerra S, Rodr\u00edguez-Baz \u00cd, Ferrer R, Carmona-Iragui M, et al. Diagnostic performance of plasma pTau217, pTau181, A\u03b21-42 and A\u03b21-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimers Res Ther. 2024;16(1):139. https:\/\/doi.org\/10.1186\/s13195-024-01513-9.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"829_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.12779\/dnd.2024.23.2.75","volume":"23","author":"GH Kim","year":"2024","unstructured":"Kim GH, Kim J, Choi W-S, Kim YK, Lee KH, Jang J-W, et al. Executive summary of 2023 International Conference of the Korean Dementia Association (IC-KDA 2023): a report from the academic committee of the Korean Dementia Association. Dement Neurocogn Disord. 2024;23(2):75\u201388. https:\/\/doi.org\/10.12779\/dnd.2024.23.2.75.","journal-title":"Dement Neurocogn Disord"},{"key":"829_CR9","doi-asserted-by":"publisher","unstructured":"Tijms BM, Vromen EM, Mjaavatten O, Holstege H, Reus LM, van der Lee S, et al. Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles. Nature Aging. 2024;4(1):33\u201347.https:\/\/doi.org\/10.12779\/dnd.2024.23.2.7510.1038\/s43587-023-00550-7.","DOI":"10.12779\/dnd.2024.23.2.7510.1038\/s43587-023-00550-7"},{"key":"829_CR10","doi-asserted-by":"publisher","unstructured":"Jamerlan AM, Shim KH, Youn YC, Teunissen C, An SSA, Scheltens P, et al. Increased oligomeric TDP-43 in the plasma of Korean frontotemporal dementia patients with semantic dementia. Alzheimers Dement. 2023;19(9):4020\u20137.https:\/\/doi.org\/10.12779\/dnd.2024.23.2.7510.1002\/alz.13127.","DOI":"10.12779\/dnd.2024.23.2.7510.1002\/alz.13127"},{"issue":"4","key":"829_CR11","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1002\/alz.13734","volume":"20","author":"KH Shim","year":"2024","unstructured":"Shim KH, Kim D, Kang MJ, Pyun JM, Park YH, Youn YC, et al. Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(4):2731\u201341. https:\/\/doi.org\/10.1002\/alz.13734.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"829_CR12","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1002\/alz.12970","volume":"19","author":"M \u010carna","year":"2023","unstructured":"\u010carna M, Onyango IG, Katina S, Holub D, Novotny JS, Nezvedova M, et al. Pathogenesis of Alzheimer\u2019s disease: involvement of the choroid plexus. Alzheimers Dement. 2023;19(8):3537\u201354. https:\/\/doi.org\/10.1002\/alz.12970.","journal-title":"Alzheimers Dement"},{"key":"829_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12975-019-00717-8","volume":"11","author":"Y Dillen","year":"2020","unstructured":"Dillen Y, Kemps H, Gervois P, Wolfs E, Bronckaers A. Adult neurogenesis in the subventricular zone and its regulation after ischemic stroke: implications for therapeutic approaches. Transl Stroke Res. 2020;11:60\u201379. https:\/\/doi.org\/10.1007\/s12975-019-00717-8.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"829_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-024-00555-3","volume":"21","author":"A Delvenne","year":"2024","unstructured":"Delvenne A, Vandendriessche C, Gobom J, Burgelman M, Dujardin P, De Nolf C, et al. Involvement of the choroid plexus in Alzheimer\u2019s disease pathophysiology: findings from mouse and human proteomic studies. Fluids Barriers CNS. 2024;21(1):58. https:\/\/doi.org\/10.1186\/s12987-024-00555-3.","journal-title":"Fluids Barriers CNS"},{"key":"829_CR15","doi-asserted-by":"publisher","unstructured":"Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer\u2019s A\u03b2 peptide: The many roads to perdition. Neuron. 2004;43(5):605\u20138.https:\/\/doi.org\/10.1016\/j.neuron.2004.08.024.","DOI":"10.1016\/j.neuron.2004.08.024"},{"issue":"7","key":"829_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070948","volume":"16","author":"S Petralla","year":"2024","unstructured":"Petralla S, Panayotova M, Franchina E, Fricker G, Puris E. Low-density lipoprotein receptor-related protein 1 as a potential therapeutic target in Alzheimer\u2019s disease. Pharmaceutics. 2024;16(7):948. https:\/\/doi.org\/10.3390\/pharmaceutics16070948.","journal-title":"Pharmaceutics"},{"issue":"4","key":"829_CR17","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/jad-180098","volume":"63","author":"Z Cai","year":"2018","unstructured":"Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q. Role of blood-brain barrier in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;63(4):1223\u201334. https:\/\/doi.org\/10.3233\/jad-180098.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"829_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020386","volume":"14","author":"S Kim","year":"2025","unstructured":"Kim S, Jung UJ, Kim SR. The crucial role of the blood\u2013brain barrier in neurodegenerative diseases: mechanisms of disruption and therapeutic implications. J Clin Med. 2025;14(2):386. https:\/\/doi.org\/10.3390\/jcm14020386.","journal-title":"J Clin Med"},{"issue":"2","key":"829_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296\u2013302. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032.","journal-title":"Neuron"},{"issue":"15","key":"829_CR20","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1002\/cne.23355","volume":"521","author":"F Langlet","year":"2013","unstructured":"Langlet F, Mullier A, Bouret SG, Prevot V, Dehouck B. Tanycyte-like cells form a blood\u2013cerebrospinal fluid barrier in the circumventricular organs of the mouse brain. J Comp Neurol. 2013;521(15):3389\u2013405. https:\/\/doi.org\/10.1002\/cne.23355.","journal-title":"J Comp Neurol"},{"issue":"6","key":"829_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/jcbfm.1987.120","volume":"7","author":"PM Gross","year":"1987","unstructured":"Gross PM, Weindl A, Knigge KM. Peering through the windows of the brain. J Cereb Blood Flow Metab. 1987;7(6):663\u201372. https:\/\/doi.org\/10.1038\/jcbfm.1987.120.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"829_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/cne.22273","volume":"518","author":"A Mullier","year":"2010","unstructured":"Mullier A, Bouret SG, Prevot V, Dehouck B. Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain. J Comp Neurol. 2010;518(7):943\u201362. https:\/\/doi.org\/10.1002\/cne.22273.","journal-title":"J Comp Neurol"},{"issue":"6","key":"829_CR23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.4103\/nrr.Nrr-d-23-01865","volume":"20","author":"G Qi","year":"2025","unstructured":"Qi G, Tang H, Hu J, Kang S, Qin S. Potential role of tanycyte-derived neurogenesis in Alzheimer\u2019s disease. Neural Regen Res. 2025;20(6):1599\u2013612. https:\/\/doi.org\/10.4103\/nrr.Nrr-d-23-01865.","journal-title":"Neural Regen Res"},{"issue":"1","key":"829_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01520-w","volume":"16","author":"J Jiang","year":"2024","unstructured":"Jiang J, Zhuo Z, Wang A, Li W, Jiang S, Duan Y, et al. Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer\u2019s continuum. Alzheimers Res Ther. 2024;16(1):149. https:\/\/doi.org\/10.1186\/s13195-024-01520-w.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"829_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-024-00601-0","volume":"21","author":"Y Hidaka","year":"2024","unstructured":"Hidaka Y, Hashimoto M, Suehiro T, Fukuhara R, Ishikawa T, Tsunoda N, et al. Association between choroid plexus volume and cognitive function in community-dwelling older adults without dementia: a population-based cross-sectional analysis. Fluids Barriers CNS. 2024;21(1):101. https:\/\/doi.org\/10.1186\/s12987-024-00601-0.","journal-title":"Fluids Barriers CNS"},{"key":"829_CR26","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1038\/s41380-024-02886-x","volume":"30","author":"M Diez-Cirarda","year":"2025","unstructured":"Diez-Cirarda M, Yus-Fuertes M, Delgado-Alonso C, Gil-Mart\u00ednez L, Jim\u00e9nez-Garc\u00eda C, Gil-Moreno MJ, et al. Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes. Mol Psychiatry. 2025;30:2821\u201330. https:\/\/doi.org\/10.1038\/s41380-024-02886-x.","journal-title":"Mol Psychiatry"},{"key":"829_CR27","doi-asserted-by":"publisher","unstructured":"Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre AG, et al. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer\u2019s disease in people with mild cognitive impairment. Cochrane Database Syst Rev. 2020(3):CD009628.https:\/\/doi.org\/10.1002\/14651858.CD009628.pub2.","DOI":"10.1002\/14651858.CD009628.pub2"},{"issue":"3","key":"829_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1148\/radiol.212400","volume":"304","author":"JD Choi","year":"2022","unstructured":"Choi JD, Moon Y, Kim H-J, Yim Y, Lee S, Moon W-J. Choroid plexus volume and permeability at brain MRI within the Alzheimer disease clinical spectrum. Radiology. 2022;304(3):635\u201345. https:\/\/doi.org\/10.1148\/radiol.212400.","journal-title":"Radiology"},{"issue":"S3","key":"829_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/alz.066276","volume":"19","author":"P Lu","year":"2023","unstructured":"Lu P, Li J, Zhao L. Increased apparent blood flow and volume of the choroid plexus in the Alzheimer\u2019s disease patients. Alzheimers Dement. 2023;19(S3):e066276. https:\/\/doi.org\/10.1002\/alz.066276.","journal-title":"Alzheimers Dement"},{"key":"829_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fncel.2015.00017","volume":"9","author":"I Gonz\u00e1lez-Marrero","year":"2015","unstructured":"Gonz\u00e1lez-Marrero I, Gim\u00e9nez-Llort L, Johanson CE, Carmona-Calero EM, Casta\u00f1eyra-Ruiz L, Brito-Armas JM, et al. Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer\u2019s disease. Front Cell Neurosci. 2015;9:17. https:\/\/doi.org\/10.3389\/fncel.2015.00017.","journal-title":"Front Cell Neurosci"},{"key":"829_CR31","doi-asserted-by":"publisher","unstructured":"Bouhrara M, Walker KA, JS RA, Gong Z, Mazucanti CH, Lewis A, et al. Association of plasma markers of Alzheimer\u2019s Disease, neurodegeneration, and neuroinflammation with the choroid plexus integrity in aging. Aging Dis. 2024;15(5):2230\u201340.https:\/\/doi.org\/10.14336\/ad.2023.1226.","DOI":"10.14336\/ad.2023.1226"},{"key":"829_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2025.100550","volume":"38","author":"S Samadzadeh","year":"2025","unstructured":"Samadzadeh S, Sleator RD. The role of neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: advancing clinical applications. eNeurolSci. 2025;38:100550. https:\/\/doi.org\/10.1016\/j.ensci.2025.100550.","journal-title":"eNeurolSci"},{"issue":"1","key":"829_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03418-8","volume":"22","author":"X Wang","year":"2024","unstructured":"Wang X, Shi Z, Qiu Y, Sun D, Zhou H. Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank. BMC Med. 2024;22(1):192. https:\/\/doi.org\/10.1186\/s12916-024-03418-8.","journal-title":"BMC Med"},{"issue":"3","key":"829_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/acn3.51730","volume":"10","author":"KA Walker","year":"2023","unstructured":"Walker KA, Duggan MR, Gong Z, Dark HE, Laporte JP, Faulkner ME, et al. MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging. Ann Clin Transl Neurol. 2023;10(3):397\u2013407. https:\/\/doi.org\/10.1002\/acn3.51730.","journal-title":"Ann Clin Transl Neurol"},{"key":"829_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neurobiolaging.2020.01.005","volume":"89","author":"E Tadayon","year":"2020","unstructured":"Tadayon E, Pascual-Leone A, Press D, Santarnecchi E. Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer\u2019s and Parkinson\u2019s disease. Neurobiol Aging. 2020;89:108\u201317. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.01.005.","journal-title":"Neurobiol Aging"},{"issue":"24","key":"829_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells11243994","volume":"11","author":"K Ando","year":"2022","unstructured":"Ando K, Nagaraj S, K\u00fc\u00e7\u00fckali F, de Fisenne MA, Kosa AC, Doeraene E, et al. PICALM and Alzheimer\u2019s disease: an update and perspectives. Cells. 2022;11(24):3994. https:\/\/doi.org\/10.3390\/cells11243994.","journal-title":"Cells"},{"key":"829_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00244","volume":"9","author":"DG Walker","year":"2017","unstructured":"Walker DG, Tang TM, Lue L-F. Studies on colony stimulating factor receptor-1 and ligands colony stimulating factor-1 and interleukin-34 in Alzheimer\u2019s disease brains and human microglia. Front Aging Neurosci. 2017;9:244. https:\/\/doi.org\/10.3389\/fnagi.2017.00244.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"829_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cne.20729","volume":"492","author":"G Banisadr","year":"2005","unstructured":"Banisadr G, Gosselin RD, Mechighel P, Rost\u00e8ne W, Kitabgi P, M\u00e9lik Parsadaniantz S. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1\/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol. 2005;492(2):178\u201392. https:\/\/doi.org\/10.1002\/cne.20729.","journal-title":"J Comp Neurol"},{"issue":"3","key":"829_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1750-3639.2008.00188.x","volume":"19","author":"A Sokolova","year":"2009","unstructured":"Sokolova A, Hill MD, Rahimi F, Warden LA, Halliday GM, Shepherd CE. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer\u2019s disease. Brain Pathol. 2009;19(3):392\u20138. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00188.x.","journal-title":"Brain Pathol"},{"issue":"1","key":"829_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030525","volume":"7","author":"K Westin","year":"2012","unstructured":"Westin K, Buchhave P, Nielsen H, Minthon L, Janciauskiene S, Hansson O. CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u2019s disease. PLoS One. 2012;7(1):e30525. https:\/\/doi.org\/10.1371\/journal.pone.0030525.","journal-title":"PLoS One"},{"issue":"3","key":"829_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000071001","volume":"16","author":"YX Sun","year":"2003","unstructured":"Sun YX, Minthon L, Wallmark A, Warkentin S, Blennow K, Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2003;16(3):136\u201344. https:\/\/doi.org\/10.1159\/000071001.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"829_CR42","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","volume":"8","author":"W-J Lee","year":"2018","unstructured":"Lee W-J, Liao Y-C, Wang Y-F, Lin IF, Wang S-J, Fuh J-L. Plasma MCP-1 and cognitive decline in patients with Alzheimer\u2019s disease and mild cognitive impairment: a two-year follow-up study. Sci Rep. 2018;8(1):1280. https:\/\/doi.org\/10.1038\/s41598-018-19807-y.","journal-title":"Sci Rep"},{"key":"829_CR43","doi-asserted-by":"publisher","unstructured":"Wang H, Zong Y, Zhu L, Wang W, Han Y. Chemokines in patients with Alzheimer\u2019s disease: A meta-analysis. Front Aging Neurosci. 2023;15:1047810.https:\/\/doi.org\/10.3389\/fnagi.2023.1047810.","DOI":"10.3389\/fnagi.2023.1047810"},{"issue":"1","key":"829_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/alz.12612","volume":"19","author":"K Connolly","year":"2023","unstructured":"Connolly K, Lehoux M, O\u2019Rourke R, Assetta B, Erdemir GA, Elias JA, et al. Potential role of chitinase-3-like protein 1 (CHI3L1\/YKL-40) in neurodegeneration and Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(1):9\u201324. https:\/\/doi.org\/10.1002\/alz.12612.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"829_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","volume":"56","author":"JE Yu","year":"2024","unstructured":"Yu JE, Yeo IJ, Han S-B, Yun J, Kim B, Yong YJ, et al. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med. 2024;56(1):1\u201318. https:\/\/doi.org\/10.1038\/s12276-023-01131-9.","journal-title":"Exp Mol Med"},{"issue":"1","key":"829_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00801-8","volume":"20","author":"PF Mwale","year":"2025","unstructured":"Mwale PF, Hsieh C-T, Yen T-L, Jan J-S, Taliyan R, Yang C-H, et al. Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications. Mol Neurodegener. 2025;20(1):7. https:\/\/doi.org\/10.1186\/s13024-025-00801-8.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"829_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02970-z","volume":"20","author":"X Zeng","year":"2023","unstructured":"Zeng X, Cheung SKK, Shi M, Or PMY, Li Z, Liu JYH, et al. Astrocyte-specific knockout of YKL-40\/Chi3l1 reduces A\u03b2 burden and restores memory functions in 5xFAD mice. J Neuroinflammation. 2023;20(1):290. https:\/\/doi.org\/10.1186\/s12974-023-02970-z.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"829_CR48","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","volume":"68","author":"R Craig-Schapiro","year":"2010","unstructured":"Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol Psychiatry. 2010;68(10):903\u201312. https:\/\/doi.org\/10.1016\/j.biopsych.2010.08.025.","journal-title":"Biol Psychiatry"},{"key":"829_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/17590914231198980","volume":"15","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, Wergeland S, Oveland E, B\u00f8 L. An association of chitinase-3 like-protein-1 with neuronal deterioration in multiple sclerosis. ASN Neuro. 2023;15:17590914231198980. https:\/\/doi.org\/10.1177\/17590914231198980.","journal-title":"ASN Neuro"},{"key":"829_CR50","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00415-011-6087-9","volume":"258","author":"J Choi","year":"2011","unstructured":"Choi J, Lee H-W, Suk K. Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer\u2019s disease. J Neurol. 2011;258:2181\u20135. https:\/\/doi.org\/10.1007\/s00415-011-6087-9.","journal-title":"J Neurol"},{"issue":"1","key":"829_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1531-3","volume":"16","author":"A Villar-Piqu\u00e9","year":"2019","unstructured":"Villar-Piqu\u00e9 A, Schmitz M, Hermann P, Goebel S, Bunck T, Varges D, et al. Plasma YKL-40 in the spectrum of neurodegenerative dementia. J Neuroinflammation. 2019;16(1):145. https:\/\/doi.org\/10.1186\/s12974-019-1531-3.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"829_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13101364","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Tian J, Ni J, Wei M, Li T, Shi J. Peripheral blood and cerebrospinal fluid levels of YKL-40 in Alzheimer\u2019s disease: a systematic review and meta-analysis. Brain Sci. 2023;13(10):1364. https:\/\/doi.org\/10.3390\/brainsci13101364.","journal-title":"Brain Sci"},{"key":"829_CR53","doi-asserted-by":"publisher","unstructured":"Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, et al. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2022;18(6):1141\u201354.https:\/\/doi.org\/10.1002\/alz.12447.","DOI":"10.1002\/alz.12447"},{"issue":"1","key":"829_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12291","volume":"14","author":"D Shir","year":"2022","unstructured":"Shir D, Graff-Radford J, Hofrenning EI, Lesnick TG, Przybelski SA, Lowe VJ, et al. Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer\u2019s disease and vascular pathology. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2022;14(1):e12291. https:\/\/doi.org\/10.1002\/dad2.12291.","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"1","key":"829_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neumar.2025.100038","volume":"2","author":"J Marksteiner","year":"2025","unstructured":"Marksteiner J, Humpel C. Glial fibrillary acidic protein as a biomarker for diagnosis of Alzheimer\u2019s disease in cerebrospinal fluid, plasma and saliva measured with lumipulse technology: a narrative review. Neuro Markers. 2025;2(1):100038. https:\/\/doi.org\/10.1016\/j.neumar.2025.100038.","journal-title":"Neuro Markers"},{"issue":"6","key":"829_CR56","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.immuni.2012.11.001","volume":"37","author":"M Greter","year":"2012","unstructured":"Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, et al. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity. 2012;37(6):1050\u201360. https:\/\/doi.org\/10.1016\/j.immuni.2012.11.001.","journal-title":"Immunity"},{"issue":"9","key":"829_CR57","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.7150\/ijbs.35070","volume":"15","author":"Y Ge","year":"2019","unstructured":"Ge Y, Huang M, Yao Y-m. Immunomodulation of interleukin-34 and its potential significance as a disease biomarker and therapeutic target. Int J Biol Sci. 2019;15(9):1835. https:\/\/doi.org\/10.7150\/ijbs.35070.","journal-title":"Int J Biol Sci"},{"key":"829_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115435","volume":"166","author":"A Ho","year":"2023","unstructured":"Ho A, Ngala B, Yamada C, Garcia C, Duarte C, Akkaoui J, et al. IL-34 exacerbates pathogenic features of Alzheimer\u2019s disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice. Biomed Pharmacother. 2023;166:115435. https:\/\/doi.org\/10.1016\/j.biopha.2023.115435.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"829_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2012.08.071","volume":"529","author":"D Ma","year":"2012","unstructured":"Ma D, Doi Y, Jin S, Li E, Sonobe Y, Takeuchi H, et al. TGF-\u03b2 induced by interleukin-34-stimulated microglia regulates microglial proliferation and attenuates oligomeric amyloid \u03b2 neurotoxicity. Neurosci Lett. 2012;529(1):86\u201391. https:\/\/doi.org\/10.1016\/j.neulet.2012.08.071.","journal-title":"Neurosci Lett"},{"issue":"12","key":"829_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115981","volume":"9","author":"S Jin","year":"2014","unstructured":"Jin S, Sonobe Y, Kawanokuchi J, Horiuchi H, Cheng Y, Wang Y, et al. Interleukin-34 restores blood\u2013brain barrier integrity by upregulating tight junction proteins in endothelial cells. PLoS One. 2014;9(12):e115981. https:\/\/doi.org\/10.1371\/journal.pone.0115981.","journal-title":"PLoS One"},{"issue":"6","key":"829_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-025-06376-4","volume":"29","author":"R Clark","year":"2025","unstructured":"Clark R, Lira-Junior R, Jansson L, Eriksdotter M, Schultzberg M, Pussinen P, et al. Elevated levels of salivary interleukin-34 in patients suffering from Alzheimer\u2019s disease. Clin Oral Investig. 2025;29(6):303. https:\/\/doi.org\/10.1007\/s00784-025-06376-4.","journal-title":"Clin Oral Investig"},{"issue":"1\u20132","key":"829_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0006-8993(03)02344-8","volume":"970","author":"S Deb","year":"2003","unstructured":"Deb S, Zhang JW, Gottschall PE. \u0392-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Res. 2003;970(1\u20132):205\u201313. https:\/\/doi.org\/10.1016\/s0006-8993(03)02344-8.","journal-title":"Brain Res"},{"issue":"3","key":"829_CR63","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.10671","volume":"54","author":"JM Lee","year":"2003","unstructured":"Lee JM, Yin KJ, Hsin I, Chen S, Fryer JD, Holtzman DM, et al. Matrix metalloproteinase\u20139 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy. Ann Neurol. 2003;54(3):379\u201382. https:\/\/doi.org\/10.1002\/ana.10671.","journal-title":"Ann Neurol"},{"issue":"9","key":"829_CR64","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.neurobiolaging.2008.08.017","volume":"31","author":"T Vargas","year":"2010","unstructured":"Vargas T, Ugalde C, Spuch C, Antequera D, Mor\u00e1n MJ, Mart\u00edn MA, et al. A\u03b2 accumulation in choroid plexus is associated with mitochondrial-induced apoptosis. Neurobiol Aging. 2010;31(9):1569\u201381. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.08.017.","journal-title":"Neurobiol Aging"},{"key":"829_CR65","doi-asserted-by":"publisher","unstructured":"Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, et al. S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. Science. 2002;297(5584):1186\u201390.https:\/\/doi.org\/10.1126\/science.1073634.","DOI":"10.1126\/science.1073634"},{"issue":"25","key":"829_CR66","doi-asserted-by":"publisher","first-page":"8733","DOI":"10.1523\/JNEUROSCI.23-25-08733.2003","volume":"23","author":"GW Kim","year":"2003","unstructured":"Kim GW, Gasche Y, Grzeschik S, Copin J-C, Maier CM, Chan PH. Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption? J Neurosci. 2003;23(25):8733\u201342. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-25-08733.2003.","journal-title":"J Neurosci"},{"key":"829_CR67","doi-asserted-by":"publisher","unstructured":"Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, et al. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer\u2019s disease. Neurochem Int. 2003;43(3):191\u20136.https:\/\/doi.org\/10.1016\/S0197-0186(03)00004-4.","DOI":"10.1016\/S0197-0186(03)00004-4"},{"issue":"9","key":"829_CR68","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/acn3.51155","volume":"7","author":"D Gu","year":"2020","unstructured":"Gu D, Liu F, Meng M, Zhang L, Gordon ML, Wang Y, et al. Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2020;7(9):1681\u201391. https:\/\/doi.org\/10.1002\/acn3.51155.","journal-title":"Ann Clin Transl Neurol"},{"key":"829_CR69","doi-asserted-by":"publisher","unstructured":"Perveen A, Mir RA, Gulfishan M, Hafeez A. MMP-3 and MMP-9 concentrations in Alzheimer\u2019s disease: A cerebrospinal fluid and serum analysis. Educ Adm Theory Pract 2024;30(4):6248\u201354.https:\/\/doi.org\/10.53555\/kuey.v30i4.2371.","DOI":"10.53555\/kuey.v30i4.2371"},{"issue":"2","key":"829_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020224","volume":"10","author":"T Gi\u00e3o","year":"2022","unstructured":"Gi\u00e3o T, Teixeira T, Almeida MR, Cardoso I. Choroid plexus in Alzheimer\u2019s disease-the current state of knowledge. Biomedicines. 2022;10(2):224. https:\/\/doi.org\/10.3390\/biomedicines10020224.","journal-title":"Biomedicines"},{"key":"829_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105937","volume":"176","author":"K G\u00f6tze","year":"2023","unstructured":"G\u00f6tze K, Vrillon A, Bouaziz-Amar E, Mouton-Liger F, Hugon J, Martinet M, et al. Plasma neurofilament light chain in memory clinic practice: evidence from a real-life study. Neurobiol Dis. 2023;176:105937. https:\/\/doi.org\/10.1016\/j.nbd.2022.105937.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"829_CR72","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","volume":"269","author":"G Giacomucci","year":"2022","unstructured":"Giacomucci G, Mazzeo S, Bagnoli S, Ingannato A, Leccese D, Berti V, et al. Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment. J Neurol. 2022;269(8):4270\u201380. https:\/\/doi.org\/10.1007\/s00415-022-11055-5.","journal-title":"J Neurol"},{"key":"829_CR73","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.dadm.2019.08.002","volume":"11","author":"AL Benedet","year":"2019","unstructured":"Benedet AL, Ashton NJ, Pascoal TA, Leuzy A, Mathotaarachchi S, Kang MS, et al. Plasma neurofilament light associates with Alzheimer\u2019s disease metabolic decline in amyloid-positive individuals. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2019;11:679\u201389. https:\/\/doi.org\/10.1016\/j.dadm.2019.08.002.","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"829_CR74","doi-asserted-by":"publisher","unstructured":"Malek-Ahmadi M, Su Y, Ghisays V, Luo J, Devadas V, Chen Y, et al. Plasma NfL is associated with the APOE \u03b54 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults. Alzheimers Res Ther. 2023;15(1):74.https:\/\/doi.org\/10.1186\/s13195-023-01221-w.","DOI":"10.1186\/s13195-023-01221-w"},{"issue":"7","key":"829_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070824","volume":"14","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Zivadinov R, Qureshi F, Ramanathan M, Weinstock-Guttman B, Tavazzi E, et al. Serum biomarker signatures of choroid plexus volume changes in multiple sclerosis. Biomolecules. 2024;14(7):824. https:\/\/doi.org\/10.3390\/biom14070824.","journal-title":"Biomolecules"},{"issue":"5","key":"829_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70239","volume":"21","author":"X Xu","year":"2025","unstructured":"Xu X, Yang X, Zhang J, Wang Y, Selim M, Zheng Y, et al. Choroid plexus free-water correlates with glymphatic function in Alzheimer\u2019s disease. Alzheimers Dement. 2025;21(5):e70239. https:\/\/doi.org\/10.1002\/alz.70239.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"829_CR77","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1172\/JCI119864","volume":"100","author":"S Monte","year":"1997","unstructured":"Monte S, Ghanbari K, Frey WH, Beheshti I, Averback P, Hauser SL, et al. Characterization of the AD7C-NTP cDNA expression in Alzheimer\u2019s disease and measurement of a 41-kD protein in cerebrospinal fluid. J Clin Invest. 1997;100(12):3093\u2013104. https:\/\/doi.org\/10.1172\/JCI119864.","journal-title":"J Clin Invest"},{"issue":"1","key":"829_CR78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JAD-131445","volume":"40","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang C-H, Li R-J, Lin X-L, Chen Y-D, Gao H-Q, et al. Accuracy of urinary AD7c-NTP for diagnosing Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;40(1):153\u20139. https:\/\/doi.org\/10.3233\/JAD-131445.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"829_CR79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3233\/JAD-170383","volume":"60","author":"N Zhang","year":"2017","unstructured":"Zhang N, Zhang L, Li Y, Gordon ML, Cai L, Wang Y, et al. Urine AD7c-NTP predicts amyloid deposition and symptom of agitation in patients with Alzheimer\u2019s disease and mild cognitive impairment. J Alzheimers Dis. 2017;60(1):87\u201395. https:\/\/doi.org\/10.3233\/JAD-170383.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"829_CR80","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jamda.2010.03.004","volume":"12","author":"YC Youn","year":"2011","unstructured":"Youn YC, Park K-W, Han S-H, Kim S. Urine neural thread protein measurements in Alzheimer disease. J Am Med Dir Assoc. 2011;12(5):372\u20136. https:\/\/doi.org\/10.1016\/j.jamda.2010.03.004.","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"829_CR81","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jocn.2014.10.011","volume":"22","author":"L Ma","year":"2015","unstructured":"Ma L, Chen J, Wang R, Han Y, Zhang J, Dong W, et al. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment. J Clin Neurosci. 2015;22(4):649\u201352. https:\/\/doi.org\/10.1016\/j.jocn.2014.10.011.","journal-title":"J Clin Neurosci"},{"issue":"21","key":"829_CR82","first-page":"1613","volume":"94","author":"Y Chen","year":"2014","unstructured":"Chen Y, Shi S, Zhang J, Gao H, Liu H, Wang J, et al. Diagnostic value of AD7C-NTP for patients with mild cognitive impairment due to Alzheimer\u2019s disease. Zhonghua Yi Xue Za Zhi. 2014;94(21):1613\u20137.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"829_CR83","doi-asserted-by":"publisher","unstructured":"Sanguinetti C, Minniti M, Susini V, Caponi L, Panichella G, Castiglione V, et al. The journey of human transthyretin: Synthesis, structure stability, and catabolism. Biomedicines. 2022;10(8):1906.https:\/\/doi.org\/10.3390\/biomedicines10081906.","DOI":"10.3390\/biomedicines10081906"},{"issue":"1","key":"829_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115133","volume":"44","author":"M Tanabe","year":"2025","unstructured":"Tanabe M, Saito Y, Takasaki A, Nakano K, Yamamoto S, Suzuki C, et al. Role of immature choroid plexus in the pathology of model mice and human iPSC-derived organoids with autism spectrum disorder. Cell Rep. 2025;44(1):115133. https:\/\/doi.org\/10.1016\/j.celrep.2024.115133.","journal-title":"Cell Rep"},{"key":"829_CR85","doi-asserted-by":"publisher","unstructured":"Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, et al. Transthyretin protects Alzheimer\u2019s mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A. 2008;105(7):2681\u20136.https:\/\/doi.org\/10.1073\/pnas.0712197105.","DOI":"10.1073\/pnas.0712197105"},{"issue":"2","key":"829_CR86","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3233\/JAD-131355","volume":"39","author":"CA Ribeiro","year":"2014","unstructured":"Ribeiro CA, Oliveira SM, Guido LF, Magalh\u00e3es A, Valencia G, Arsequell G, et al. Transthyretin stabilization by iododiflunisal promotes amyloid-\u03b2 peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer\u2019s disease mouse model. J Alzheimers Dis. 2014;39(2):357\u201370. https:\/\/doi.org\/10.3233\/JAD-131355.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"829_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55318-0","volume":"9","author":"Y-T Tien","year":"2019","unstructured":"Tien Y-T, Lee W-J, Liao Y-C, Wang W-F, Jhang K-M, Wang S-J, et al. Plasma transthyretin as a predictor of amnestic mild cognitive impairment conversion to dementia. Sci Rep. 2019;9(1):18691. https:\/\/doi.org\/10.1038\/s41598-019-55318-0.","journal-title":"Sci Rep"},{"issue":"1","key":"829_CR88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/jad-2011-102145","volume":"25","author":"SH Han","year":"2011","unstructured":"Han SH, Jung ES, Sohn JH, Hong HJ, Hong HS, Kim JW, et al. Human serum transthyretin levels correlate inversely with Alzheimer\u2019s disease. J Alzheimers Dis. 2011;25(1):77\u201384. https:\/\/doi.org\/10.3233\/jad-2011-102145.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"829_CR89","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2174\/156720512803251057","volume":"9","author":"CA Ribeiro","year":"2012","unstructured":"Ribeiro CA, Santana I, Oliveira C, Baldeiras I, Moreira J, Saraiva MJ, et al. Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation. Curr Alzheimer Res. 2012;9(8):881\u20139. https:\/\/doi.org\/10.2174\/156720512803251057.","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"829_CR90","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/jad-2011-110611","volume":"28","author":"L Velayudhan","year":"2012","unstructured":"Velayudhan L, Killick R, Hye A, Kinsey A, G\u00fcntert A, Lynham S, et al. Plasma transthyretin as a candidate marker for Alzheimer\u2019s disease. J Alzheimers Dis. 2012;28(2):369\u201375. https:\/\/doi.org\/10.3233\/jad-2011-110611.","journal-title":"J Alzheimers Dis"},{"key":"829_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.139394","volume":"294","author":"S Wang","year":"2025","unstructured":"Wang S, Xi J, Zhang M, Wang J. Identification of potential therapeutic targets for Alzheimer\u2019s disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study. Int J Biol Macromol. 2025;294:139394. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139394.","journal-title":"Int J Biol Macromol"},{"key":"829_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1221775","volume":"14","author":"DF Leitner","year":"2023","unstructured":"Leitner DF, Kanshin E, Faustin A, Thierry M, Friedman D, Devore S, et al. Localized proteomic differences in the choroid plexus of Alzheimer\u2019s disease and epilepsy patients. Front Neurol. 2023;14:1221775. https:\/\/doi.org\/10.3389\/fneur.2023.1221775.","journal-title":"Front Neurol"},{"issue":"1","key":"829_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02807-w","volume":"148","author":"B Ghetti","year":"2024","unstructured":"Ghetti B, Schweighauser M, Jacobsen MH, Gray D, Bacioglu M, Murzin AG, et al. TMEM106B amyloid filaments in the Biondi bodies of ependymal cells. Acta Neuropathol. 2024;148(1):60. https:\/\/doi.org\/10.1007\/s00401-024-02807-w.","journal-title":"Acta Neuropathol"},{"key":"829_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2024.108986","volume":"142","author":"Y Yokoyama","year":"2025","unstructured":"Yokoyama Y, Harada R, Kudo K, Iwata R, Kudo Y, Okamura N, et al. Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus. Nucl Med Biol. 2025;142:108986. https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108986.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"829_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-024-00557-1","volume":"21","author":"T Chen","year":"2024","unstructured":"Chen T, Dai Y, Hu C, Lin Z, Wang S, Yang J, et al. Cellular and molecular mechanisms of the blood\u2013brain barrier dysfunction in neurodegenerative diseases. Fluids Barriers CNS. 2024;21(1):60. https:\/\/doi.org\/10.1186\/s12987-024-00557-1.","journal-title":"Fluids Barriers CNS"},{"issue":"12","key":"829_CR96","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/brain\/awaa325","volume":"143","author":"BM Tijms","year":"2020","unstructured":"Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, et al. Pathophysiological subtypes of Alzheimer\u2019s disease based on cerebrospinal fluid proteomics. Brain. 2020;143(12):3776\u201392. https:\/\/doi.org\/10.1093\/brain\/awaa325.","journal-title":"Brain"},{"key":"829_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2023.107213","volume":"152","author":"F Khan","year":"2023","unstructured":"Khan F, Qiu H. Amyloid-\u03b2: a potential mediator of aging-related vascular pathologies. Vasc Pharmacol. 2023;152:107213. https:\/\/doi.org\/10.1016\/j.vph.2023.107213.","journal-title":"Vasc Pharmacol"},{"issue":"11","key":"829_CR98","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.ajpath.2021.07.003","volume":"191","author":"TV Procter","year":"2021","unstructured":"Procter TV, Williams A, Montagne A. Interplay between brain pericytes and endothelial cells in dementia. Am J Pathol. 2021;191(11):1917\u201331. https:\/\/doi.org\/10.1016\/j.ajpath.2021.07.003.","journal-title":"Am J Pathol"},{"key":"829_CR99","doi-asserted-by":"publisher","unstructured":"Montagne A, Nikolakopoulou AM, Zhao Z, Sagare AP, Si G, Lazic D, et al. Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med. 2018;24(3):326\u201337.https:\/\/doi.org\/10.1038\/nm.4482.","DOI":"10.1038\/nm.4482"},{"issue":"4","key":"829_CR100","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/s0002-9440(10)63905-3","volume":"162","author":"P Guo","year":"2003","unstructured":"Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJ, et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol. 2003;162(4):1083\u201393. https:\/\/doi.org\/10.1016\/s0002-9440(10)63905-3.","journal-title":"Am J Pathol"},{"issue":"6","key":"829_CR101","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4103\/1673-5374.130117","volume":"9","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Peng D, Yuan X, Lv Z, Pang S, Jiang W, et al. APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer\u2019s disease. Neural Regen Res. 2014;9(6):653\u201360. https:\/\/doi.org\/10.4103\/1673-5374.130117.","journal-title":"Neural Regen Res"},{"issue":"1","key":"829_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087017","volume":"9","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Zhao F, Lv Z-p, Zheng C-g, Zheng W-d, Sun L, et al. Association between APOC1 polymorphism and Alzheimer\u2019s disease: a case-control study and meta-analysis. PLoS One. 2014;9(1):e87017. https:\/\/doi.org\/10.1371\/journal.pone.0087017.","journal-title":"PLoS One"},{"issue":"1","key":"829_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-192","volume":"9","author":"E Cudaback","year":"2012","unstructured":"Cudaback E, Li X, Yang Y, Yoo T, Montine KS, Craft S, et al. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. J Neuroinflammation. 2012;9(1):192. https:\/\/doi.org\/10.1186\/1742-2094-9-192.","journal-title":"J Neuroinflammation"},{"issue":"24","key":"829_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417415","volume":"24","author":"CH Lee","year":"2023","unstructured":"Lee CH, Murrell CE, Chu A, Pan X. Circadian regulation of apolipoproteins in the brain: implications in lipid metabolism and disease. Int J Mol Sci. 2023;24(24):17415. https:\/\/doi.org\/10.3390\/ijms242417415.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"829_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713064","volume":"24","author":"M Inoue","year":"2023","unstructured":"Inoue M, Suzuki H, Meno K, Liu S, Korenaga T, Uchida K. Identification of plasma proteins as biomarkers for mild cognitive impairment and Alzheimer\u2019s disease using liquid chromatography\u2013tandem mass spectrometry. Int J Mol Sci. 2023;24(17):13064. https:\/\/doi.org\/10.3390\/ijms241713064.","journal-title":"Int J Mol Sci"},{"key":"829_CR106","doi-asserted-by":"publisher","unstructured":"De Boer J, Creasey A, Chang A, Abbink J, Roem D, Eerenberg A, et al. Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model. Infect Immun. 1993;61(12):5035\u201343.https:\/\/doi.org\/10.1128\/iai.61.12.5035-5043.1993.","DOI":"10.1128\/iai.61.12.5035-5043.1993"},{"issue":"1","key":"829_CR107","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/mp.2016.206","volume":"22","author":"V Varma","year":"2017","unstructured":"Varma V, Varma S, An Y, Hohman T, Seddighi S, Casanova R, et al. Alpha-2 macroglobulin in Alzheimer\u2019s disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry. 2017;22(1):13\u201323. https:\/\/doi.org\/10.1038\/mp.2016.206.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"829_CR108","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/01.Res.0000218275.54089.12","volume":"98","author":"NP Brindle","year":"2006","unstructured":"Brindle NP, Saharinen P, Alitalo K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res. 2006;98(8):1014\u201323. https:\/\/doi.org\/10.1161\/01.Res.0000218275.54089.12.","journal-title":"Circ Res"},{"key":"829_CR109","doi-asserted-by":"publisher","unstructured":"Schreitm\u00fcller B, Leyhe T, Stransky E, K\u00f6hler N, Laske C. Elevated angiopoietin-1 serum levels in patients with Alzheimer\u2019s disease. Int J Alzheimers Dis. 2012;2012:324016.https:\/\/doi.org\/10.1155\/2012\/324016.","DOI":"10.1155\/2012\/324016"},{"key":"829_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117430","volume":"246","author":"Z Peng","year":"2020","unstructured":"Peng Z, Luo Y, Xiao Z-Y. Angiopoietin-1 accelerates Alzheimer\u2019s disease via FOXA2\/PEN2\/APP pathway in APP\/PS1 mice. Life Sci. 2020;246:117430. https:\/\/doi.org\/10.1016\/j.lfs.2020.117430.","journal-title":"Life Sci"},{"key":"829_CR111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.exger.2014.10.004","volume":"60","author":"J Oh","year":"2014","unstructured":"Oh J, Lee HJ, Song JH, Park SI, Kim H. Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer\u2019s disease. Exp Gerontol. 2014;60:87\u201391. https:\/\/doi.org\/10.1016\/j.exger.2014.10.004.","journal-title":"Exp Gerontol"},{"issue":"9","key":"829_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091074","volume":"15","author":"F Angelucci","year":"2022","unstructured":"Angelucci F, Veverova K, Katonov\u00e1 A, Piendel L, Vyhnalek M, Hort J. Alzheimer\u2019s disease severity is associated with an imbalance in serum levels of enzymes regulating plasmin synthesis. Pharmaceuticals. 2022;15(9):1074. https:\/\/doi.org\/10.3390\/ph15091074.","journal-title":"Pharmaceuticals"},{"issue":"25","key":"829_CR113","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1073\/pnas.0710823105","volume":"105","author":"JS Jacobsen","year":"2008","unstructured":"Jacobsen JS, Comery TA, Martone RL, Elokdah H, Crandall DL, Oganesian A, et al. Enhanced clearance of A\u03b2 in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci U S A. 2008;105(25):8754\u20139. https:\/\/doi.org\/10.1073\/pnas.0710823105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"829_CR114","doi-asserted-by":"publisher","unstructured":"Tang MY, Gorin FA, Lein PJ. Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer\u2019s disease. Ageing Neurodegener Dis. 2022;2.https:\/\/doi.org\/10.20517\/and.2022.05.","DOI":"10.20517\/and.2022.05"},{"issue":"39","key":"829_CR115","doi-asserted-by":"publisher","first-page":"36025","DOI":"10.1021\/acsomega.3c04076","volume":"8","author":"F Angelucci","year":"2023","unstructured":"Angelucci F, Veverova K, Katonov\u00e1 A, Vyhnalek M, Hort J. Serum PAI-1\/BDNF ratio is increased in Alzheimer\u2019s disease and correlates with disease severity. ACS Omega. 2023;8(39):36025\u201331. https:\/\/doi.org\/10.1021\/acsomega.3c04076.","journal-title":"ACS Omega"},{"issue":"4","key":"829_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040711","volume":"13","author":"LB Payne","year":"2023","unstructured":"Payne LB, Abdelazim H, Hoque M, Barnes A, Mironovova Z, Willi CE, et al. A soluble platelet-derived growth factor receptor-\u03b2 originates via pre-mRNA splicing in the healthy brain and is upregulated during hypoxia and aging. Biomolecules. 2023;13(4):711. https:\/\/doi.org\/10.3390\/biom13040711.","journal-title":"Biomolecules"},{"issue":"1","key":"829_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0534-8","volume":"11","author":"JS Miners","year":"2019","unstructured":"Miners JS, Kehoe PG, Love S, Zetterberg H, Blennow K. CSF evidence of pericyte damage in Alzheimer\u2019s disease is associated with markers of blood-brain barrier dysfunction and disease pathology. Alzheimers Res Ther. 2019;11(1):81. https:\/\/doi.org\/10.1186\/s13195-019-0534-8.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"829_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00512-w","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang J, Fan DY, Li HY, He CY, Shen YY, Zeng GH, et al. Dynamic changes of CSF sPDGFR\u03b2 during ageing and AD progression and associations with CSF ATN biomarkers. Mol Neurodegener. 2022;17(1):9. https:\/\/doi.org\/10.1186\/s13024-021-00512-w.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"829_CR119","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1021\/pr200270z","volume":"10","author":"L Ijsselstijn","year":"2011","unstructured":"Ijsselstijn L, Dekker LJM, Stingl C, van der Weiden MM, Hofman A, Kros JM, et al. Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer\u2019s disease. J Proteome Res. 2011;10(11):4902\u201310. https:\/\/doi.org\/10.1021\/pr200270z.","journal-title":"J Proteome Res"},{"issue":"1","key":"829_CR120","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/jad-131628","volume":"46","author":"DAT Nijholt","year":"2015","unstructured":"Nijholt DAT, Ijsselstijn L, van der Weiden MM, Zheng P-P, Sillevis Smitt PAE, Koudstaal PJ, et al. Pregnancy zone protein is increased in the Alzheimer\u2019s disease brain and associates with senile plaques. J Alzheimers Dis. 2015;46(1):227\u201338. https:\/\/doi.org\/10.3233\/jad-131628.","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"829_CR121","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1073\/pnas.1817298116","volume":"116","author":"JH Cater","year":"2019","unstructured":"Cater JH, Kumita JR, Zeineddine Abdallah R, Zhao G, Bernardo-Gancedo A, Henry A, et al. Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer\u2019s-associated amyloid beta peptide. Proc Natl Acad Sci U S A. 2019;116(13):6101\u201310. https:\/\/doi.org\/10.1073\/pnas.1817298116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"829_CR122","doi-asserted-by":"publisher","unstructured":"Prevot V, Dehouck B, Sharif A, Ciofi P, Giacobini P, Clasadonte J. The versatile tanycyte: A hypothalamic integrator of reproduction and energy metabolism. Endocr Rev. 2018;39(3):333\u201368.https:\/\/doi.org\/10.1210\/er.2017-00235.","DOI":"10.1210\/er.2017-00235"},{"issue":"3","key":"829_CR123","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12690","volume":"31","author":"E Rodr\u00edguez","year":"2019","unstructured":"Rodr\u00edguez E, Guerra M, Peruzzo B, Bl\u00e1zquez JL. Tanycytes: a rich morphological history to underpin future molecular and physiological investigations. J Neuroendocrinol. 2019;31(3):e12690. https:\/\/doi.org\/10.1111\/jne.12690.","journal-title":"J Neuroendocrinol"},{"key":"829_CR124","doi-asserted-by":"publisher","unstructured":"Sauv\u00e9 F, Ternier G, Dewisme J, Lebouvier T, Dupr\u00e9 E, Danis C, et al. Tanycytes are degraded in Alzheimer\u2019s Disease, disrupting the brain-to-blood efflux of Tau. medRxiv. 2022:2022.05.04.22274181.https:\/\/doi.org\/10.1101\/2022.05.04.22274181.","DOI":"10.1101\/2022.05.04.22274181"},{"issue":"9","key":"829_CR125","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1111\/ejn.13723","volume":"46","author":"MM Salman","year":"2017","unstructured":"Salman MM, Kitchen P, Woodroofe MN, Brown JE, Bill RM, Conner AC, et al. Hypothermia increases aquaporin 4 (AQP4) plasma membrane abundance in human primary cortical astrocytes via a calcium\/transient receptor potential vanilloid 4 (TRPV4)- and calmodulin-mediated mechanism. Eur J Neurosci. 2017;46(9):2542\u20137. https:\/\/doi.org\/10.1111\/ejn.13723.","journal-title":"Eur J Neurosci"},{"key":"829_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1258640","volume":"15","author":"Y Chen","year":"2023","unstructured":"Chen Y, He Y, Han J, Wei W, Chen F. Blood-brain barrier dysfunction and Alzheimer\u2019s disease: associations, pathogenic mechanisms, and therapeutic potential. Front Aging Neurosci. 2023;15:1258640. https:\/\/doi.org\/10.3389\/fnagi.2023.1258640.","journal-title":"Front Aging Neurosci"},{"key":"829_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-11-117","volume":"11","author":"M Pallebage-Gamarallage","year":"2012","unstructured":"Pallebage-Gamarallage M, Lam V, Takechi R, Galloway S, Clark K, Mamo J. Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis. 2012;11:117. https:\/\/doi.org\/10.1186\/1476-511X-11-117.","journal-title":"Lipids Health Dis"},{"key":"829_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103503","volume":"71","author":"CSB Singh","year":"2021","unstructured":"Singh CSB, Choi KB, Munro L, Wang HY, Pfeifer CG, Jefferies WA. Reversing pathology in a preclinical model of Alzheimer\u2019s disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. EBioMedicine. 2021;71:103503. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103503.","journal-title":"EBioMedicine"},{"issue":"1","key":"829_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00388-4","volume":"13","author":"M Zhang","year":"2024","unstructured":"Zhang M, Zhang Z, Li H, Xia Y, Xing M, Xiao C, et al. Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer\u2019s disease. Transl Neurodegener. 2024;13(1):1. https:\/\/doi.org\/10.1186\/s40035-023-00388-4.","journal-title":"Transl Neurodegener"},{"key":"829_CR130","doi-asserted-by":"publisher","unstructured":"Zeni P, Doepker E, Schulze-Topphoff U, Huewel S, Tenenbaum T, Galla HJ. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro. Am J Physiol Cell Physiol. 2007;293(3):C855\u201364.https:\/\/doi.org\/10.1152\/ajpcell.00470.2006.","DOI":"10.1152\/ajpcell.00470.2006"},{"issue":"18","key":"829_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810235","volume":"23","author":"R Versele","year":"2022","unstructured":"Versele R, Sevin E, Gosselet F, Fenart L, Candela P. TNF-\u03b1 and IL-1\u03b2 modulate blood-brain barrier permeability and decrease amyloid-\u03b2 peptide efflux in a human blood-brain barrier model. Int J Mol Sci. 2022;23(18):10235. https:\/\/doi.org\/10.3390\/ijms231810235.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"829_CR132","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4103\/1673-5374.180372","volume":"11","author":"S Balusu","year":"2016","unstructured":"Balusu S, Brkic M, Libert C, Vandenbroucke RE. The choroid plexus-cerebrospinal fluid interface in Alzheimer\u2019s disease: more than just a barrier. Neural Regen Res. 2016;11(4):534\u20137. https:\/\/doi.org\/10.4103\/1673-5374.180372.","journal-title":"Neural Regen Res"},{"issue":"8","key":"829_CR133","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tins.2024.05.010","volume":"47","author":"A Tsitsou-Kampeli","year":"2024","unstructured":"Tsitsou-Kampeli A, Suzzi S, Schwartz M. The immune and metabolic milieu of the choroid plexus as a potential target in brain protection. Trends Neurosci. 2024;47(8):573\u201382. https:\/\/doi.org\/10.1016\/j.tins.2024.05.010.","journal-title":"Trends Neurosci"},{"issue":"4","key":"829_CR134","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708300","volume":"10","author":"S Steeland","year":"2018","unstructured":"Steeland S, Gorl\u00e9 N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, et al. Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer\u2019s disease. EMBO Mol Med. 2018;10(4):e8300. https:\/\/doi.org\/10.15252\/emmm.201708300.","journal-title":"EMBO Mol Med"},{"key":"829_CR135","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.brainres.2010.10.053","volume":"1368","author":"J-Q Shi","year":"2011","unstructured":"Shi J-Q, Shen W, Chen J, Wang B-R, Zhong L-L, Zhu Y-W, et al. Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains. Brain Res. 2011;1368:239\u201347. https:\/\/doi.org\/10.1016\/j.brainres.2010.10.053.","journal-title":"Brain Res"},{"key":"829_CR136","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbr.2016.06.001","volume":"311","author":"DH Kim","year":"2016","unstructured":"Kim DH, Choi S-M, Jho J, Park M-S, Kang J, Park SJ, et al. Infliximab ameliorates AD-associated object recognition memory impairment. Behav Brain Res. 2016;311:384\u201391. https:\/\/doi.org\/10.1016\/j.bbr.2016.06.001.","journal-title":"Behav Brain Res"},{"key":"829_CR137","doi-asserted-by":"publisher","unstructured":"Lyra e Silva NM, Gon\u00e7alves RA, Pascoal TA, Lima-Filho RAS, Resende EdPF, Vieira ELM, et al. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease. Transl Psychiatry. 2021;11(1):251.https:\/\/doi.org\/10.1038\/s41398-021-01349-z.","DOI":"10.1038\/s41398-021-01349-z"},{"issue":"18","key":"829_CR138","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acschemneuro.4c00205","volume":"15","author":"T Retinasamy","year":"2024","unstructured":"Retinasamy T, Lee ALY, Lee HS, Lee VLL, Shaikh MF, Yeong KY. Repurposing Anakinra for Alzheimer\u2019s disease: The in vitro and in vivo effects of Anakinra on LPS- and AC-induced neuroinflammation. ACS Chem Neurosci. 2024;15(18):3298\u2013310. https:\/\/doi.org\/10.1021\/acschemneuro.4c00205.","journal-title":"ACS Chem Neurosci"},{"issue":"51","key":"829_CR139","doi-asserted-by":"publisher","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","volume":"271","author":"AL Biere","year":"1996","unstructured":"Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. Amyloid \u03b2-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem. 1996;271(51):32916\u201322. https:\/\/doi.org\/10.1074\/jbc.271.51.32916.","journal-title":"J Biol Chem"},{"issue":"3","key":"829_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103164","volume":"60","author":"M Costa","year":"2021","unstructured":"Costa M, P\u00e1ez A. Emerging insights into the role of albumin with plasma exchange in Alzheimer\u2019s disease management. Transfus Apher Sci. 2021;60(3):103164. https:\/\/doi.org\/10.1016\/j.transci.2021.103164.","journal-title":"Transfus Apher Sci"},{"key":"829_CR141","doi-asserted-by":"publisher","unstructured":"Boada M, Ortiz P, Anaya F, Hernandez I. Amyloid-targeted therapeutics in Alzheimer. Drug News Perspect. 2009;22(6):325.https:\/\/doi.org\/10.1358\/dnp.2009.22.6.1395256.","DOI":"10.1358\/dnp.2009.22.6.1395256"},{"issue":"1","key":"829_CR142","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-160565","volume":"56","author":"M Boada","year":"2017","unstructured":"Boada M, Anaya F, Ortiz P, Olazar\u00e1n J, Shua-Haim JR, Obisesan TO, et al. Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-\u03b2 concentrations and cognition outcomes in Alzheimer\u2019s disease patients: a multicenter, randomized, controlled clinical trial. J Alzheimers Dis. 2017;56(1):129\u201343. https:\/\/doi.org\/10.3233\/JAD-160565.","journal-title":"J Alzheimers Dis"},{"key":"829_CR143","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trci.2019.01.001","volume":"5","author":"M Boada","year":"2019","unstructured":"Boada M, L\u00f3pez O, N\u00fa\u00f1ez L, Szczepiorkowski ZM, Torres M, Grifols C, et al. Plasma exchange for Alzheimer\u2019s disease management by Albumin Replacement (AMBAR) trial: study design and progress. Alzheimers Dement (N Y). 2019;5:61\u20139. https:\/\/doi.org\/10.1016\/j.trci.2019.01.001.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"10","key":"829_CR144","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/alz.12137","volume":"16","author":"M Boada","year":"2020","unstructured":"Boada M, L\u00f3pez OL, Olazar\u00e1n J, N\u00fa\u00f1ez L, Pfeffer M, Paricio M, et al. A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer\u2019s disease: primary results of the AMBAR study. Alzheimers Dement. 2020;16(10):1412\u201325. https:\/\/doi.org\/10.1002\/alz.12137.","journal-title":"Alzheimers Dement"},{"key":"829_CR145","doi-asserted-by":"publisher","unstructured":"Arfaei R, Mikaeili N, Daj F, Boroumand A, Kheyri A, Yaraghi P, et al. Decoding the role of the CCL2\/CCR2 axis in Alzheimer\u2019s disease and innovating therapeutic approaches: Keeping all options open. International Immunopharmacology. 2024;135:112328.https:\/\/doi.org\/10.1016\/j.intimp.2024.112328.","DOI":"10.1016\/j.intimp.2024.112328"},{"issue":"1","key":"829_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01254-1","volume":"15","author":"F Zhou","year":"2023","unstructured":"Zhou F, Sun Y, Xie X, Zhao Y. Blood and CSF chemokines in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Res Ther. 2023;15(1):107. https:\/\/doi.org\/10.1186\/s13195-023-01254-1.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"829_CR147","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1007\/s12035-019-01695-6","volume":"56","author":"IL Guti\u00e9rrez","year":"2019","unstructured":"Guti\u00e9rrez IL, Gonz\u00e1lez-Prieto M, Caso JR, Garc\u00eda-Bueno B, Leza JC, Madrigal JLM. Reboxetine treatment reduces neuroinflammation and neurodegeneration in the 5xFAD mouse model of Alzheimer\u2019s disease: role of CCL2. Mol Neurobiol. 2019;56(12):8628\u201342. https:\/\/doi.org\/10.1007\/s12035-019-01695-6.","journal-title":"Mol Neurobiol"},{"key":"829_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578364","volume":"391","author":"SF Oliai","year":"2024","unstructured":"Oliai SF, Shippy DC, Ulland TK. Mitigation of CXCL10 secretion by metabolic disorder drugs in microglial-mediated neuroinflammation. J Neuroimmunol. 2024;391:578364. https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578364.","journal-title":"J Neuroimmunol"},{"key":"829_CR149","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2017.10.023","volume":"300","author":"M Tachibana","year":"2018","unstructured":"Tachibana M, Yamazaki Y, Liu C-C, Bu G, Kanekiyo T. Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-\u03b2 pathology in amyloid model mice. Exp Neurol. 2018;300:13\u201321. https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.023.","journal-title":"Exp Neurol"},{"issue":"1","key":"829_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00807-5","volume":"12","author":"J Li","year":"2022","unstructured":"Li J, Li M, Ge Y, Chen J, Ma J, Wang C, et al. \u0392-amyloid protein induces mitophagy-dependent ferroptosis through the CD36\/PINK\/PARKIN pathway leading to blood\u2013brain barrier destruction in Alzheimer\u2019s disease. Cell Biosci. 2022;12(1):69. https:\/\/doi.org\/10.1186\/s13578-022-00807-5.","journal-title":"Cell Biosci"},{"issue":"1","key":"829_CR151","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/bpa.12759","volume":"30","author":"L Fu","year":"2020","unstructured":"Fu L, Jiang G, Weng H, Dick GM, Chang Y, Kassab GS. Cerebrovascular miRNAs correlate with the clearance of A\u03b2 through perivascular route in younger 3xTg-AD mice. Brain Pathol. 2020;30(1):92\u2013105. https:\/\/doi.org\/10.1111\/bpa.12759.","journal-title":"Brain Pathol"},{"key":"829_CR152","doi-asserted-by":"publisher","unstructured":"Nortley R, Korte N, Izquierdo P, Hirunpattarasilp C, Mishra A, Jaunmuktane Z, et al. Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes. Science. 2019;365(6450):eaav9518.https:\/\/doi.org\/10.1126\/science.aav9518.","DOI":"10.1126\/science.aav9518"},{"issue":"1","key":"829_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12785-7","volume":"7","author":"J Kaneko","year":"2017","unstructured":"Kaneko J, Enya A, Enomoto K, Ding Q, Hisatsune T. Anserine (beta-alanyl-3-methyl-L-histidine) improves neurovascular-unit dysfunction and spatial memory in aged A\u03b2PPswe\/PSEN1dE9 Alzheimer\u2019s-model mice. Sci Rep. 2017;7(1):12571. https:\/\/doi.org\/10.1038\/s41598-017-12785-7.","journal-title":"Sci Rep"},{"key":"829_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114825","volume":"379","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Mu B-R, Ran Z, Zhu T, Huang X, Yang X, et al. Pericytes in Alzheimer\u2019s disease: key players and therapeutic targets. Exp Neurol. 2024;379:114825. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114825.","journal-title":"Exp Neurol"},{"issue":"1","key":"829_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19042-y","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Huang Y, Gong J, Wang J, Fan Y, Cai J, et al. Transplantation of hPSC-derived pericyte-like cells promotes functional recovery in ischemic stroke mice. Nat Commun. 2020;11(1):5196. https:\/\/doi.org\/10.1038\/s41467-020-19042-y.","journal-title":"Nat Commun"},{"key":"829_CR156","doi-asserted-by":"publisher","unstructured":"Rust R, Sagare AP, Kisler K, Kim Y, Zhang M, Griffin C, et al. Molecular signature and functional properties of human pluripotent stem cell-derived brain pericytes. bioRxiv. 2025.https:\/\/doi.org\/10.1101\/2023.06.26.546577.","DOI":"10.1101\/2023.06.26.546577"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00829-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:03:28Z","timestamp":1758877408000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":156,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00829-4","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and Consent to Participate Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate declaration"}},{"value":"HZ serves at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and was a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which was a part of the GU Ventures Incubator Program (outside submitted work). The rest of the authors have nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}